Kylie’s POV.

I sit at the head of the conference table, projecting confidence as I present Novalife’s latest business proposal. The client, a significant player in the pharmaceutical industry, listens intently, nodding occasionally. Their interest is palpable, and I can sense the deal slipping into our grasp.

“With our expanded production capabilities,” I explain, “Novalife can seamlessly fill the gap left by Flora’s company. We assure you not only ...